SMO - smoothened, frizzled class receptor Gene
Species: Felis catus
Gene Type: protein coding
Gene ID: 101087567
SMO Products (2)
| mRNA | Protein | Name |
|---|---|---|
| XM_011280558.3 | XP_011278860.3 | smoothened homolog isoform X1 |
| XM_045052739.1 | XP_044908674.1 | smoothened homolog isoform X2 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
smoothened homolog |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(6)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-16582A | Sonidegib | Antagonist | 99.98% | Yes |
| HY-16391 | Glasdegib | Inhibitor | 99.65% | Yes |
| HY-B0603 | Fluticasone | Agonist | 98.70% | Yes |
| HY-16582 | Sonidegib diphosphate | Antagonist | 99.97% | Yes |
| HY-B0877 | Halcinonide | Agonist | 98.29% | Unkown |
| HY-16391A | Glasdegib maleate | Inhibitor | / | Unkown |
Clinical Phase
Bioactive Molecules
(5)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-13654 | IPI-269609 | Inhibitor | / | Phase 4 |
| HY-16587 | Saridegib | Inhibitor | 99.95% | Phase 3 |
| HY-13809 | BMS-833923 | Inhibitor | 99.82% | Phase 2 |
| HY-13242 | Taladegib | Inhibitor | 99.92% | Phase 2 |
| HY-18636 | LEQ506 | Inhibitor | 98.92% | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(56)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-12848 | SAG | Agonist | 99.79% | Unkown |
| HY-17024 | Cyclopamine | Inhibitor | 99.97% | Unkown |
| HY-15108 | Purmorphamine | Activator | 99.94% | Unkown |
| HY-100224 | SANT-1 | Antagonist | 99.87% | Unkown |
| HY-12848B | SAG hydrochloride | Agonist | 99.91% | Unkown |
| HY-12848C | SAG dihydrochloride | Agonist | 98.23% | Unkown |
| HY-15483 | DY131 | Inhibitor | 99.72% | Unkown |
| HY-100535 | KAAD-Cyclopamine | Antagonist | ≥96.0% | Unkown |
| HY-12316 | 20(S)-Hydroxycholesterol | Activator | 99.63% | Unkown |
| HY-15108G | Purmorphamine (GMP) | Agonist | / | Unkown |
| HY-N0836 | Jervine | Inhibitor | 99.28% | Unkown |
| HY-12317 | GSA-10 | Agonist | ≥98.0% | Unkown |
| HY-13459 | PF-5274857 | Antagonist | 99.31% | Unkown |
| HY-15412 | HhAntag | 99.40% | Unkown | |
| HY-N0247 | Saikosaponin B1 | Inhibitor | 99.42% | Unkown |
| HY-151115 | JNJ-1289 | Inhibitor | 98.06% | Unkown |
| HY-12848R | SAG (Standard) | Agonist | 99.56% | Unkown |
| HY-137115 | BODIPY-Cyclopamine | 98.91% | Unkown | |
| HY-113965 | CUR61414 | Inhibitor | 99.04% | Unkown |
| HY-115566 | S1PL-IN-1 | Antagonist | 99.9% | Unkown |
| HY-100036 | MK-4101 | Antagonist | 99.16% | Unkown |
| HY-117407 | ALLO-2 | Antagonist | 99.72% | Unkown |
| HY-18287 | MRT-83 | Antagonist | 99.27% | Unkown |
| HY-18287A | MRT-83 hydrochloride | Antagonist | 99.60% | Unkown |
| HY-100224G | SANT-1 (GMP) | Antagonist | / | Unkown |
| HY-120499 | AZD8542 | Antagonist | 99.49% | Unkown |
| HY-110240 | IHR-1 | Antagonist | 98.05% | Unkown |
| HY-145387 | MRT-81 | Antagonist | 99.85% | Unkown |
| HY-108507 | MRT-10 | Antagonist | 98.99% | Unkown |
| HY-108508 | SMANT hydrochloride | Inhibitor | 99.90% | Unkown |
| HY-12316R | 20(S)-Hydroxycholesterol (Standard) | Activator | 98.69% | Unkown |
| HY-13459A | PF-5274857 hydrochloride | Antagonist | / | Unkown |
| HY-147744 | AZD7254 | Inhibitor | / | Unkown |
| HY-150567 | SMO-IN-3 | Inhibitor | / | Unkown |
| HY-12848S | SAG-d3 | Inhibitor | 99.85% | Unkown |
| HY-16391S1 | Glasdegib-d4 | Inhibitor | / | Unkown |
| HY-177291 | LAB687 | Antagonist | / | Unkown |
| HY-183335 | SMO-IN-6 | Inhibitor | / | Unkown |
| HY-148440 | RL-0070933 | Modulator | / | Unkown |
| HY-162372 | Hedgehog IN-6 | Inhibitor | / | Unkown |
| HY-162273 | Antibacterial agent 189 | / | Unkown | |
| HY-12848A | (Rac)-SAG | Agonist | / | Unkown |
| HY-16391B | Glasdegib hydrochloride | Inhibitor | / | Unkown |
| HY-159893 | SMO-IN-5 | Inhibitor | / | Unkown |
| HY-147743 | SMO-IN-1 | Inhibitor | / | Unkown |
| HY-110326 | Smo antagonist M25 | Antagonist | / | Unkown |
| HY-131016 | IHR-Cy3 | Antagonist | / | Unkown |
| HY-147670 | TPB15 | Inhibitor | / | Unkown |
| HY-145918 | MRT-14 | Antagonist | 98.91% | Unkown |
| HY-153499 | SMO-IN-4 | Antagonist | / | Unkown |
| HY-123752 | MS-0022 | Antagonist | / | Unkown |
| HY-16587A | Saridegib hydrochloride | Inhibitor | / | Unkown |
| HY-150564 | SMO-IN-2 | Inhibitor | 98.12% | Unkown |
| HY-117903A | MRT-92 | Antagonist | / | Unkown |
| HY-133974 | 7-keto-25-Hydroxycholesterol | Activator | / | Unkown |
| HY-12848G | SAG (GMP) | Agonist | / | Unkown |
Bioactive MoleculesInhibitory Antibodies
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P990418 | Anti-FZD7 Antibody | / | Unkown |